A Bioinformatics Pipeline for Investigating Molecular Evolution and Gene Expression using RNA-seq
May 28th, 2021
8.8K views
The purpose of this protocol is to investigate the evolution and expression of candidate genes using RNA sequencing data.
Overview
This protocol investigates the molecular evolution and expression of candidate genes by employing RNA sequencing data, specifically focusing on opsin genes in Hydra vulgaris. The study showcases a bioinformatic pipeline that can be applied to various organisms.
Key Study Components
Research Area
- Gene expression analysis
- Molecular evolution
- Bioinformatics
Background
- Investigates candidate genes relevant to light detection and eye evolution
- Utilizes the freshwater invertebrate Hydra vulgaris
- Employs NCBI resources for sequence data retrieval
Methods Used
- Bioinformatic pipeline for RNA sequencing
- Hydra vulgaris as the biological system
- Tools like BLAST, MEGA, and edgeR for analysis
Main Results
- Identified opsin genes evolving through lineage-specific duplications in Cnidarians
- Found differential expression of 1,774 transcripts in various body parts
- Generated a maximum-likelihood phylogenetic tree of opsin sequences
Conclusions
- The protocol highlights the potential of candidate genes for future functional studies
- Advances our understanding of gene evolution and expression in relation to sensory biology
Frequently Asked Questions
What are candidate genes and why are they important?
Candidate genes are genes that are implicated in specific biological functions or traits, making them crucial for understanding genetic influences on development and evolution.
How can this bioinformatic protocol be applied to other organisms?
The pipeline is versatile and can be adapted to study any gene family across various species with the appropriate sequence data.
What technology is primarily used in this research?
RNA sequencing along with bioinformatic analysis tools such as BLAST and MEGA are used in this research.
What challenges are typically faced in bioinformatics protocols?
Common challenges include software compatibility issues, script failures, and proper data management throughout the analysis.
What role does differential expression analysis play?
Differential expression analysis identifies genes that show significant changes in expression levels across different conditions or tissues, providing insights into functional roles.
How do the results contribute to future studies?
The findings from this protocol can guide further research into gene functions and evolutionary relationships, aiding in broader biological understanding.
Executive Industry Relevance
This bioinformatics pipeline enables systematic investigation of gene family evolution and expression, supporting target validation through mechanistic de-risking in early discovery. By integrating phylogenetic analysis with RNA-seq quantification, it provides predictive confidence for prioritizing candidate genes with conserved or divergent functions across species. The approach aids portfolio triage by identifying mechanistically informed hypotheses before committing resources to functional studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by clarifying gene orthology and evolutionary relationships within target families.
- Operational Value: Enables functional target validation through comparative expression profiling across tissues and developmental stages.
- Predictive Value: Supports lead identification by highlighting genes with lineage-specific expansions and tissue-enriched expression patterns.
Screening & Assay Development
- Scientific Value: Prepares validated gene sets for downstream screening by confirming family membership through sequence alignment and tree topology.
- Operational Value: Generates standardized count matrices from RNA-seq data, enabling reproducible quantitative outputs for assay readiness.
- Scalability: Facilitates platform reuse across organisms by applying consistent BLAST, alignment, and phylogenetic workflows.
Translational & Preclinical Research
- Translational Continuity: Connects discovery-phase expression data to preclinical models by identifying conserved expression patterns in relevant tissues.
- Biomarker Alignment: Supports translational biomarker discovery through differential expression analysis across conditions, such as hypostome versus body column in Hydra.
- Risk-Adjusted Advancement: Informs go/no-go decisions by revealing expression dynamics during regeneration and budding stages, indicating functional relevance.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target identification through lead optimization, enabling hypothesis-driven progression from sequence analysis to functional prioritization.
- Discovery Biology: Supports hypothesis testing by generating phylogenies that reveal duplication events and selection pressures on gene families of interest.
- Screening: Delivers assay-ready biological systems through normalized expression matrices that allow cross-sample comparison of gene activity.
- Analytics: Provides quantitative dependent variable measurements via edgeR-based differential expression, enabling statistical comparison of conditions.
- Translational Research: Connects to preclinical continuity by identifying genes with conserved roles in sensory systems across metazoans.
- Enterprise Reuse: Establishes a reusable bioinformatic capability for interrogating any gene family, reducing redundant pipeline development across projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target selection by reducing mechanistic ambiguity through evolutionary and expression context.
- Operational Value: Enhances reproducibility and standardization via documented, stepwise bioinformatic procedures applicable across teams.
- Strategic Value: Improves capital efficiency by enabling early de-risking of targets before investment in wet-lab validation.
- Portfolio Impact: Supports risk-adjusted prioritization by highlighting genes with strong evolutionary conservation and tissue-specific induction.
Implementation Considerations
- Requires expertise in bioinformatics, including command-line tools, sequence databases, and phylogenetic software.
- Depends on access to computational infrastructure for handling large RNA-seq datasets and running BLAST, MEGA, and edgeR analyses.
- Necessitates cross-team standardization on file naming, reference genome versions, and parameter settings for alignment and tree building.
- Involves adaptation considerations when applying the pipeline to non-model organisms with incomplete genomes or annotations.
- Limited by the quality and completeness of input data, including RNA-seq depth and reference genome annotation accuracy.
Biopharma FAQs
Why does phylogenetic analysis support target validation?
Phylogenetic analysis clarifies orthology and evolutionary relationships, helping distinguish true gene family members from paralogs or unrelated sequences. This reduces false positives in target selection by confirming evolutionary conservation or lineage-specific expansion. Such insights increase confidence in mechanistic hypotheses before functional testing.
How does isolating independent variables improve discovery pipeline reliability?
Isolating independent variables, such as tissue type or developmental stage, enables clear attribution of expression changes to specific biological conditions. This supports reproducible comparisons across samples, which is essential for target validation and biomarker discovery. Controlled variables reduce noise and increase the signal-to-noise ratio in expression datasets.
What do quantitative dependent variable measurements enable in target prioritization?
Quantitative measurements, such as normalized read counts and fold-change values, allow objective comparison of gene expression across conditions. These metrics support statistical testing and help identify consistently upregulated or downregulated candidates. Such data inform prioritization decisions by highlighting genes with strong, reproducible expression patterns.
Why are replication requirements important for cross-functional collaboration?
Replication ensures that expression and phylogenetic results are robust and not driven by technical artifacts or batch effects. Consistent results across replicates build confidence when sharing findings between computational and experimental teams. This reliability is critical for aligning bioinformatic predictions with wet-lab validation efforts.
What statistical analysis capabilities are required before implementing this pipeline?
Implementation requires capability to perform differential expression analysis using tools like edgeR, including normalization, dispersion estimation, and statistical testing. Users must be able to generate count matrices and apply appropriate models for pairwise comparisons. Familiarity with false discovery rate correction and threshold setting is also necessary for interpreting results.
